Kizlaitienė , R., et al. “Recommendations for the Treatment of Multiple Sclerosis With Disease-Modifying Drugs During the COVID-19 Pandemic”. Neurologijos Seminarai, vol. 24, no. 2(84), June 2020, pp. 100-4, https://doi.org/10.29014/ns.2020.13.